OKLAHOMA CITY, April 24, 2020 /PRNewswire/ -- Continental Resources, Inc. (NYSE: CLR) ("Continental" or the "Company") today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and Oklahoma authorities, the location of its annual meeting has been changed to a virtual format.
Logo - https://mma.prnewswire.com/media/95419/continental_resources_logo.jpg
As previously announced, the annual meeting will be held on Thursday, May 14, 2020 at 10:00 a.m., Central Daylight Time ("CDT"). Online access to the meeting will begin at 9:45 a.m. CDT. The annual meeting will be presented in audio only format. Shareholders will not be able to attend the annual meeting in person. Information regarding attending the virtual meeting, including the meeting rules, can be found by visiting http://www.CLR.com.
Registering to Attend the Virtual Meeting as a Shareholder of Record
If you were a shareholder of record as of March 18, 2020 (i.e., you held your shares in your own name as reflected in the records of our transfer agent, American Stock Transfer & Trust Company ("AST")), you can attend the meeting and register to participate in the annual meeting by accessing https://web.lumiagm.com/294221297 and selecting the button "I have a Control Number." You will then be directed to a screen where you will enter: (i) the 11-digit control number on the proxy card previously sent to you by AST; and (ii) the meeting password "continental2020". Please note the meeting password is case sensitive. Once you have completed these steps, select the "login" button, which will take you to the annual meeting page where you can vote, submit written questions and listen to the meeting (referred to in this release as the "Meeting Page").
Registering to Attend the Annual Meeting as a Beneficial Owner
If you were a beneficial owner of record as of March 18, 2020 (i.e., you held your shares in an account at a brokerage firm, bank or other similar agent), you will need to obtain a legal proxy from your broker, bank or other agent to register to participate in the annual meeting. Once you have received a legal proxy from your broker, bank or other agent, it should be emailed to our transfer agent, AST, at proxy@astfinancial.com, and should be labeled "request for Co. #15389 control number" in the subject line. Requests for registration must be received by AST no later than 5:00 p.m. Eastern Daylight Time, on Friday, May 8, 2020. You will then receive a confirmation of your registration, with an 11-digit control number, by email from AST. At the time of the meeting, follow the directions appearing above under the heading "Registering to Attend the Virtual Meeting as a Shareholder of Record", except you will enter the 11-digit control number received as a result of submitting your legal proxy to AST.
Only shareholders of record and beneficial owners of record who have registered as described above will be allowed to vote and ask questions during the annual meeting.
Asking Questions
If you are attending the annual meeting as a shareholder of record or beneficial owner, who has registered for the meeting, you can ask questions by clicking the messaging icon on the right side of the toolbar appearing at the top of the Meeting Page and then typing and submitting your question.
Voting Shares
If you are attending the annual meeting as a shareholder of record or beneficial owner and you have registered for the meeting, you can vote during the meeting by clicking the link "Proxy Voting Site" on the Meeting Page and following the prompts.
Whether you plan to attend the annual meeting, we urge you to vote in advance of the meeting by one of the methods described in the proxy materials for the annual meeting.
The proxy materials previously distributed, including the proxy card sent to registered holders and the notice regarding the availability of proxy materials sent to beneficial owners, will not be updated to reflect the change in location and may continue to be used to vote your shares in connection with the annual meeting.
Attending the Annual Meeting as a Guest
If you are a record holder or beneficial owner and would like to enter the annual meeting as a guest in listen-only mode, go to https://web.lumiagm.com/294221297 and select the button "I am a guest". Please note you will not have the ability to ask questions or vote during the meeting if you participate as a guest.
Inspection of Shareholder Lists
Continental's offices are currently closed to the public in compliance with recommendations and orders from federal and Oklahoma authorities related to the coronavirus (COVID-19) pandemic. Shareholders wishing to inspect shareholder lists in advance of the annual meeting should send an email to ShareholderList@clr.com and follow the instructions received in response to the email.
About Continental Resources
Continental Resources (NYSE: CLR) is a top 10 independent oil producer in the U.S. Lower 48 and a leader in America's energy renaissance. Based in Oklahoma City, Continental is the largest leaseholder and the largest producer in the nation's premier oil field, the Bakken play of North Dakota and Montana. The Company also has significant positions in Oklahoma, including its SCOOP Woodford and SCOOP Springer discoveries and the STACK plays. With a focus on the exploration and production of oil, Continental has unlocked the technology and resources vital to American energy independence and our nation's leadership in the new world oil market. In 2020, the Company will celebrate 53 years of operations. For more information, please visit http://www.CLR.com.
CareATC Now Offers COVID-19 Antibody Detection Testing to Help Inform Return-to-Work Strategies
TULSA, Okla.--(BUSINESS WIRE)--Apr 28, 2020--
CareATC, a leader in workforce population health management, is now offering a rapid COVID-19 antibody detection test to member employers in an effort to help inform return-to-work strategies.
"As employers are considering return-to-work plans, CareATC is leading the way by offering COVID-19 antibody testing early on," says Scott Stickland, CareATC President and COO. "Our goal is to be as proactive as possible so that our member employers and their employees can take the first steps toward recovery."
Understanding Antibody Testing
In general, antibodies begin to be produced by the immune system a few days after infection starts and remain positive long after the infection ends. This is why an antibody test can be useful to detect a past infection with coronavirus and determine some evidence of potential immunity.
"Antibodies can be detected a couple different ways through blood testing. By taking blood from a vein, we can quantify how many antibodies a person has, which helps determine their immune status. Currently there are several laboratories working to gain this capability," says Dr. Kim Hutton, CareATC Chief Medical Officer. "Another way to test immunity is to conduct a rapid antibody test, which is qualitative. It tells us if antibodies are detected, but it does not tell us how much of each antibody is present in the body. Rapid tests can be conducted with a drop of blood from a finger prick in many different settings." Though the test does not convey how many of each antibody is present, it is regarded as a preliminary step that may be helpful to know if some immunity is present in an employee.
Distribution of COVID-19 Antibody Detection Tests
CareATC is beginning to offer antibody detection testing to member employers. If a patient displays symptoms of COVID-19, including a mild cough, runny nose, sore throat, shortness of breath, or difficulty breathing, and is still recovering, he or she should wait until asymptomatic or more than seven days has elapsed since onset.
All patients will need to consult a CareATC physician via a virtual visit or in person before they can be considered for COVID-19 antibody tests. Depending on the testing method, results are typically available within 20 minutes for a rapid test or two-to-three days for a blood draw.
CareATC expects to offer the intravenous version of the antibody blood test to member employers as soon as it becomes available, and the company has plans to incorporate it into upcoming Personal Health Assessment events and at CareATC clinics for member employers who elect to offer it to their employees.
Known Antibody Test Limitations
It is important to note that the rapid antibody test is not yet FDA approved. There are currently no FDA approved SAR-Cov2 antibody tests available. A positive antibody test does not mean immunity.
In some cases, a CareATC physician may recommend an additional nasopharyngeal PCR test or serial rapid antibody testing to make better predictions about immunity.
"CareATC is dedicated to continuing the fight against COVID-19 and providing our employers the information required to make the best decisions for their employees," says Strickland. "We remain committed to educating ourselves and our employer partners and to provide the most up-to-date information possible."
About CareATC, Inc.
CareATC Inc. is a leading innovator in the health technology sector providing on-site and shared-site medical clinics. By leveraging groundbreaking technology, CareATC offers customized population health management solutions for employers that reduce healthcare costs by promoting health, preventing disease and providing a shorter path to care. CareATC manages more than 150 clients in 35 states and cares for more than 300,000 patients. Accredited by the Accreditation Association for Ambulatory Health Care Inc., CareATC is based in Tulsa, Oklahoma. To learn more about CareATC Inc., visit http://www.careatc.com.
Reader Comments(0)